Form 4 Filing for Arcutis Biotherapeutics, Inc.

This filing details transactions by Keith R. Leonard, a director at Arcutis Biotherapeutics, Inc. (ARQT). On June 5, 2026, Leonard acquired 5,778 shares of Common Stock through Restricted Stock Units (RSUs) granted in connection with his director service, which vest on the first anniversary of the grant date or immediately before the next annual meeting, subject to continued service. The settlement of these RSUs has been deferred. Additionally, Leonard acquired a Stock Option to purchase 16,667 shares of Common Stock, with vesting and exercisability conditions similar to the RSUs. The option has an exercise price of $21.23 and expires on June 5, 2036. The filing also notes 1,750 shares held indirectly through the Leonard Family Trust dated August 28, 1996, of which Leonard is a trustee.